Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998–2009): comparison with non-invasive isolates
- 15 April 2011
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 30 (10) , 1295-1302
Abstract
The incidence, clinical manifestations, and circulating clones involved in Streptococcus pyogenes invasive disease was analyzed in two regions of Spain between 1998 and 2009. The annual average incidence of invasive disease was 2 episodes per 100,000 inhabitants (3.1 for children and 1.9 for adults). The most frequent clinical manifestations were cellulitis (41.3%), bacteremia without focus (19.0%), streptococcal toxic shock syndrome (12.6%), and pneumonia (7.7%). Among 247 invasive isolates analyzed, the most prevalent clones were emm1/ST28 (27.9%), emm3/ST15-406 (9.8%), and emm4/ST39 (6.5%). The emm1/ST28 clone was the only clone detected each year throughout the study period and was associated with more than one third of all fatal outcomes. When invasive isolates were compared with 1,189 non-invasive isolates, the emm1/ST28 clone was significantly associated with invasive disease. The speA and ssa genes were more frequent among invasive emm1 and emm4 isolates, respectively. Forty-two (17%) invasive isolates were resistant to erythromycin (21 harbored the mef gene and 21 the ermB or ermA genes). Twenty-two (8.9%) isolates had reduced susceptibility to ciprofloxacin (minimum inhibitory concentration [MIC] 2–8 μg/mL) and 32 (13%) were tetracycline-resistant (tetM or tetO gene). In conclusion, the emm1 type was overrepresented among invasive cases and was associated with high mortality rates.Keywords
This publication has 35 references indexed in Scilit:
- Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 cloneBMC Infectious Diseases, 2010
- Emergence of Ciprofloxacin-Nonsusceptible Streptococcus pyogenes Isolates from Healthy Children and Pediatric Patients in PortugalAntimicrobial Agents and Chemotherapy, 2010
- Streptococcus pyogenes Isolates Causing Severe Infections in Norway in 2006 to 2007: emm Types, Multilocus Sequence Types, and Superantigen ProfilesJournal of Clinical Microbiology, 2010
- Clinical and Microbial Characteristics of Invasive Streptococcus pyogenes Disease in New Caledonia, a Region in Oceania with a High Incidence of Acute Rheumatic FeverJournal of Clinical Microbiology, 2010
- Prevalence and Clonal Characterization of Streptococcus pyogenes Clinical Isolates with Reduced Fluoroquinolone Susceptibility in SpainAntimicrobial Agents and Chemotherapy, 2010
- Clinical and Microbiological Characteristics of SevereStreptococcus pyogenesDisease in EuropeJournal of Clinical Microbiology, 2009
- Rise and Persistence of Global M1T1 Clone ofStreptococcus pyogenesEmerging Infectious Diseases, 2008
- Clinical and Epidemiological Aspects of Invasive Streptococcus pyogenes Infections in Denmark during 2003 and 2004Journal of Clinical Microbiology, 2008
- Invasive Group A Streptococcal Infection in Older Adults in Long-term Care Facilities and the Community, United States, 1998–20031Emerging Infectious Diseases, 2007
- Phenotypic and Genotypic Characterization of Streptococcus pyogenes Isolates Displaying the MLS B Phenotype of Macrolide Resistance in Spain, 1999 to 2005Antimicrobial Agents and Chemotherapy, 2007